Usefulness of Polygenic Risk Score for Intraventricular Septal Diameter in Patients With Hypertrophic Cardiomyopathy

被引：0
|
作者：
Nomura, Akihiro
Sato, Takehiro
Noguchi, Masahiro
Takeji, Yasuaki
Tada, Hayato
Hayashi, Kenshi
Tajima, Atsushi
Takamura, Masayuki
Fujino, Noboru
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Hypertrophic cardiomyopathy; Polygenic Risk;
D O I：
10.1161/circ.148.suppl_1.17207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A17207
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Surgical outcome for hypertrophic cardiomyopathy patients with extreme interventricular septal thickness: a propensity score matched study
    Ren, Changwei
    Wang, Shengwei
    Yu, Jianbo
    Guo, Hongchang
    Ma, Hehe
    Wei, Zhipeng
    Liu, Kemin
    Lai, Yongqiang
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5460 - +
  • [22] Intraventricular septal intramural asynchrony in patients with hypertrophic cardiomyopathy using tissue velocity Imaging correlates with the severity of myocardial fibrosis
    Tanaka, Jun
    Nakatani, Satoshi
    Tanaka, Toshiyuki
    Amaki, Makoto
    Kamiya, Chizuko
    Hashimoto, Shuji
    Kanzaki, Hideaki
    Ishibashi-Ueda, Hatsue
    Kitakaze, Masafumi
    CIRCULATION, 2007, 116 (16) : 545 - 545
  • [23] Usefulness of Cardiac Magnetic Resonance Imaging in the Clinical Risk Stratification in Patients With Hypertrophic Cardiomyopathy
    Oikawa, Minako
    Takii, Toru
    Miyamichi, Saori
    Sugimura, Koichiro
    Fukumoto, Yoshihiro
    Shimokawa, Hiroaki
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (07) : S163 - S163
  • [24] The Usefulness of Microvolt T-Wave Alternans in the Risk Stratification of Patients with Hypertrophic Cardiomyopathy
    Fuchs, Therese
    Torjman, Amram
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (10): : 606 - 610
  • [25] Usefulness of Cardiac Magnetic Resonance Imaging in the Clinical Risk Stratification in Patients With Hypertrophic Cardiomyopathy
    Oikawa, Minako
    Takii, Toru
    Miyamichi, Saori
    Sugimura, Koichiro
    Fukumoto, Yoshihiro
    Shimokawa, Hiroaki
    CIRCULATION, 2009, 120 (18) : S779 - S779
  • [26] Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy
    Monakier, D
    Woo, A
    Puri, T
    Schwartz, L
    Ross, J
    Jamorski, M
    Yang, H
    Liu, Z
    Vannan, M
    Wigle, ED
    Rakowski, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (12): : 1515 - 1522
  • [27] Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Amelie Burghardt
    Frank van Buuren
    Zisis Dimitriadis
    Tim Grübbel
    Hubert Seggewiss
    Smita Scholtz
    Dieter Horstkotte
    Lothar Faber
    Clinical Research in Cardiology, 2018, 107 : 479 - 486
  • [28] Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Burghardt, Amelie
    van Buuren, Frank
    Dimitriadis, Zisis
    Gruebbel, Tim
    Seggewiss, Hubert
    Scholtz, Smita
    Horstkotte, Dieter
    Faber, Lothar
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (06) : 479 - 486
  • [29] Impact of septal curvature on regional strain in patients with hypertrophic cardiomyopathy
    Nishimura, K.
    Okayama, H.
    Inoue, K.
    Ogimoto, A.
    Suzuki, J.
    Saito, M.
    Hiasa, G.
    Sumimoto, T.
    Funada, J.
    Higaki, J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 478 - 478
  • [30] Outcomes after septal myectomy in a cohort of patients with hypertrophic cardiomyopathy
    Lopez-Gutierrez, L., V
    Orozco-Burbano, J. D.
    Murillo-Moreno, M. A.
    Durango-Gutierrez, L. F.
    Hernandez-Aramburo, P. M.
    Gonzalez-Franco, S. G.
    Arenas, E. M. Canas
    Rendon-Isaza, J. C.
    Saldarriaga-Giraldo, Ci
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (09)
12345